Home › Uveal Melanoma › Pennsylvania › Philadelphia
Uveal Melanoma clinical trials in Philadelphia, PA
7 studies for Uveal Melanoma are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal Melanoma
RecruitingPhase 3
- Wills Eye Hospital at Thomas Jefferson University, Philadelphia
Tebentafusp-tebn With LDT in Metastatic UM
RecruitingPhase 1/2
- Thomas Jefferson University, Philadelphia
Neoadjuvant Tebentafusp for Uveal Melanoma
RecruitingPhase 2
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
RecruitingPhase 1/2
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
RecruitingPhase 1/2
- University of Pennsylvania, Perelamn Center for Advanced Medicine, Philadelphia
- Thomas Jefferson University, Honickman Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
Neoadjuvant Darovasertib in Primary Uveal Melanoma
RecruitingPhase 3
- Jefferson Health Honickman Center, Philadelphia
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
RecruitingPhase 2/3
- Thomas Jefferson University, Philadelphia
Uveal Melanoma trials in other cities
- Los Angeles, CA6 studies
- Nashville, TN6 studies
- Boston, MA5 studies
- Scottsdale, AZ5 studies
- New York City, NY5 studies
- Columbus, OH5 studies
- Houston, TX5 studies
- Denver, CO5 studies
- Pittsburgh, PA4 studies
- Aurora, CO4 studies
- Mountain View, CA4 studies
- Miami, FL4 studies
Other studies in Philadelphia
- Cancer (all types)59 studies
- Breast Cancer56 studies
- Non-Small Cell Lung Cancer51 studies
- Metastatic Cancer46 studies
- Prostate Cancer44 studies
- Colorectal Cancer44 studies
- Ovarian Cancer44 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Heart Failure31 studies
- Endometrial Cancer28 studies
- Depression26 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.